Today: 2 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

Tonix Pharmaceuticals shares fell 11% to close at $14.29 on Monday, despite receiving FDA clearance to advance its depression drug TNX-102 SL into Phase 2 trials. The stock sits near the bottom of its 52-week range after sharp volatility and recent expansion of its at-the-market stock offering program. Tonix recently launched Tonmya for fibromyalgia and reported $190.1 million in cash for Q3 2025.
25 November 2025
Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Baidu shares jumped 7.5% to $119 on November 25 after JP Morgan upgraded the stock to “Overweight” and raised its price target to $188. The rally followed a mixed Q3 report showing revenue fell 7% to RMB 31.2 billion, with continued growth in AI and cloud offsetting weakness in advertising. Institutional investors, including Sierra Summit Advisors, increased positions in recent months.
Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy shares fell 1.1% to $75.62 Monday, underperforming major indexes, with trading volume spiking to nearly 7 million shares ahead of Tuesday’s earnings report. Wall Street expects Q3 EPS of $1.31 on $9.6 billion revenue. The stock yields about 5% and trades at 21 times trailing earnings. Holiday sales forecasts remain weak, and tariffs continue to pressure margins.
25 November 2025
Kraken Robotics (PNG.V) Edges Higher After Record Q3 2025 Earnings and Strong 2025 Outlook – Stock Update for November 24, 2025

Kraken Robotics (PNG.V) Edges Higher After Record Q3 2025 Earnings and Strong 2025 Outlook – Stock Update for November 24, 2025

Kraken Robotics shares closed at C$5.39 on November 24, up C$0.03, after reporting record Q3 revenue of C$31.3 million, a 60% year-over-year increase. Trading volume surged to 2.87 million shares, well above average. Gross profit rose 81% to C$18.6 million, with gross margin improving to 59%. The company reaffirmed its full-year outlook.
MPW Stock Today (November 24, 2025): Dividend Hike, Buyback and Short Interest Drive Medical Properties Trust’s Turnaround Story

MPW Stock Today (November 24, 2025): Dividend Hike, Buyback and Short Interest Drive Medical Properties Trust’s Turnaround Story

Medical Properties Trust (NYSE: MPW) closed Monday at about $5.31 per share, little changed after announcing a 12.5% dividend increase and a $150 million buyback. The REIT’s stock is up 25% over the past year but remains down more than 50% from three years ago. Average volume slightly exceeded normal at 8.6 million shares. Market cap stands near $3.2 billion.
BFLY Stock Today: Butterfly Network Jumps on Licensing Deal, Insider Buying and AI Momentum (Nov. 24, 2025)

BFLY Stock Today: Butterfly Network Jumps on Licensing Deal, Insider Buying and AI Momentum (Nov. 24, 2025)

Butterfly Network shares jumped about 24% to $3.28–$3.29 Monday after announcing a five-year, $25 million-plus licensing deal with Midjourney for its ultrasound-on-chip technology. Trading volume topped 16 million shares. The stock’s market cap stands near $800 million, with shares swinging between $1.32 and $4.98 over the past year.
MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

Molina Healthcare shares closed up 2.6% at $145.30 Monday on heavy volume after reports of a possible extension of ACA subsidies. The stock remains down over 50% from its 52-week high following an October earnings shock and ongoing class-action lawsuits. Market cap stood at $7.5 billion, with a P/E ratio near 9x. Intraday trading ranged from $141 to $151.
24 November 2025
CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy

CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy

Clearside Biomedical filed for Chapter 11 bankruptcy Monday and will seek a court-supervised sale of its assets. CLSD stock plunged nearly 68% to around $0.88 by late afternoon, hitting a new 52-week low after closing at $2.69 Friday. Trading volume spiked to roughly 12 times normal levels. The company cited “substantial doubt” about its ability to continue as a going concern in its latest quarterly filing.
24 November 2025
GPUS Stock Today, November 24, 2025: Hyperscale Data Jumps After Joining Top 100 Bitcoin Treasuries – Price, News and Outlook

GPUS Stock Today, November 24, 2025: Hyperscale Data Jumps After Joining Top 100 Bitcoin Treasuries – Price, News and Outlook

Hyperscale Data Inc. (NYSE American: GPUS) shares rose about 12% to $0.28 Monday after the company announced it joined the global top 100 public Bitcoin treasury companies. Trading volume reached 30 million shares by mid-afternoon. GPUS stock remains down over 95% from its 52-week high near $10. The company now holds roughly 382 Bitcoin, up from 150 earlier this year.
CAVA Stock Today (Nov. 24, 2025): Price, Crash, and Outlook After the Q3 Earnings Shock

CAVA Stock Today (Nov. 24, 2025): Price, Crash, and Outlook After the Q3 Earnings Shock

Cava Group shares traded near $46.80 Monday afternoon, down about 4% and nearly 70% below last year’s high of $153.34. The stock has swung sharply this month, surging 12% on Nov. 21 before retreating. Third-quarter revenue rose 20% to $290 million, but Cava missed EPS estimates and cut its 2025 same-restaurant sales outlook. Market cap stands near $5.5 billion.
MRK Stock Today: Merck Jumps on Wells Fargo Upgrade and Keytruda Momentum (November 24, 2025)

MRK Stock Today: Merck Jumps on Wells Fargo Upgrade and Keytruda Momentum (November 24, 2025)

Merck shares climbed nearly 4% to around $101.40 by early afternoon Monday, nearing 2025 highs after Wells Fargo upgraded the stock to “Overweight” and raised its price target to $125. The move followed new FDA approvals and pipeline updates. Options activity surged, with call volume outpacing puts more than 3:1. Merck’s market cap stood at about $252 billion.
BMY Stock Soars on Factor XIa Catalyst and Hematology Investor Event (Nov. 24, 2025)

BMY Stock Soars on Factor XIa Catalyst and Hematology Investor Event (Nov. 24, 2025)

Bristol Myers Squibb shares rose 4.3% to $48.24 Monday after renewed investor interest in Factor XIa blood-thinner drugs and its candidate milvexian. The company announced a hematology-focused virtual investor event for December 11. Despite the gain, BMY remains down about 14% for the year, trailing the S&P 500’s 13.6% rise. Q3 earnings beat expectations, with revenue up 3% to $12.2 billion.
24 November 2025
BIIB Stock Today: Biogen Hits New 52‑Week High After Novo Nordisk Alzheimer’s Trial Failure (Nov. 24, 2025)

BIIB Stock Today: Biogen Hits New 52‑Week High After Novo Nordisk Alzheimer’s Trial Failure (Nov. 24, 2025)

Biogen shares hit a 52-week high Monday, closing at $177.42, up 1.2%, after Novo Nordisk’s Alzheimer’s drug failed in late-stage trials. The stock traded as high as $185.17 intraday on volume of about 2.07 million shares. Investors also reacted to Biogen’s new immunology partnership with Dayra Therapeutics. Novo shares fell sharply on the trial news.
24 November 2025
WRD Stock Jumps as WeRide’s Q3 2025 Results Spark Robotaxi Rally (Nov. 24, 2025)

WRD Stock Jumps as WeRide’s Q3 2025 Results Spark Robotaxi Rally (Nov. 24, 2025)

WeRide Inc. ADR shares jumped about 14% to $8.24 in early U.S. trading Monday after Q3 revenue rose 144% year over year to RMB 171 million (US$24 million). Robotaxi revenue soared 761% to RMB 35.3 million, now 20.7% of total sales. Net loss narrowed to RMB 307.3 million (US$43.2 million). Volume topped 7.9 million shares, above average.
1 671 672 673 674 675 679
Go toTop